Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Int J Colorectal Dis. 2021 May;36(5):959-969. doi: 10.1007/s00384-020-03794-6. Epub 2020 Nov 10.
We evaluated the impact of examined lymph node (ELN) number on the prognosis of stage II colon cancer after radical surgery and developed a novel prognostic scoring system by combining primary tumor extension (pT) and ELN number for reclassification of stage II colon cancer.
Three cohorts of patients diagnosed with colon cancer between 2004 and 2010 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate analyses were performed to evaluate the relationship between factors and patients' survival including cause-specific survival (CSS) and overall survival (OS). Survival curves from subgroups were plotted by the Kaplan-Meier method and compared by the log-rank test.
Cohort 1 and cohort 2 consisted of 13,960 and 5312 stage II colon cancer patients, respectively. Cohort 3 consisted of 4713 stage III patients. Factors including ELN, age, and pT were found to be associated with patients' survival in cohorts 1 and 2. Patients who were older or with smaller tumors were more likely to experience inadequate ELN. Patients with a higher score, as calculated by the novel scoring system, showed worse survival. Compared with stage III colon cancer patients, stage II patients with high scores had a comparable or even worse survival than stage IIIA and IIIB patients.
Inadequate ELN leads to understaging in stage II colon cancer and predicts inferior prognosis. Our analyses show that the novel prognostic scoring system, consisting of combined pT and ELN, quantified stage migration effect and can be applied to the reclassification of stage II colon cancer.
我们评估了根治性手术后检查淋巴结(ELN)数量对 II 期结肠癌预后的影响,并通过结合原发肿瘤延伸(pT)和 ELN 数量开发了一种新的预后评分系统,用于重新分类 II 期结肠癌。
从监测、流行病学和最终结果(SEER)数据库中确定了 2004 年至 2010 年间诊断为结肠癌的三个队列的患者。进行单因素和多因素分析,以评估包括特异性生存(CSS)和总体生存(OS)在内的因素与患者生存之间的关系。通过 Kaplan-Meier 方法绘制亚组的生存曲线,并通过对数秩检验进行比较。
队列 1 和队列 2 分别包含 13960 例和 5312 例 II 期结肠癌患者。队列 3 包含 4713 例 III 期患者。在队列 1 和队列 2 中,ELN、年龄和 pT 等因素与患者的生存有关。年龄较大或肿瘤较小的患者更可能出现 ELN 不足。根据新的评分系统计算的评分较高的患者生存情况较差。与 III 期结肠癌患者相比,评分较高的 II 期患者的生存情况与 IIIA 期和 IIIB 期患者相当甚至更差。
ELN 不足导致 II 期结肠癌分期不足,并预测预后不良。我们的分析表明,由联合 pT 和 ELN 组成的新的预后评分系统量化了分期迁移效应,可应用于 II 期结肠癌的重新分类。